Short needles (8 mm) reduce the risk of intramuscular injections in children with type 1 diabetes

Citation
N. Tubiana-rufi et al., Short needles (8 mm) reduce the risk of intramuscular injections in children with type 1 diabetes, DIABET CARE, 22(10), 1999, pp. 1621-1625
Citations number
16
Categorie Soggetti
Endocrynology, Metabolism & Nutrition","Endocrinology, Nutrition & Metabolism
Journal title
DIABETES CARE
ISSN journal
01495992 → ACNP
Volume
22
Issue
10
Year of publication
1999
Pages
1621 - 1625
Database
ISI
SICI code
0149-5992(199910)22:10<1621:SN(MRT>2.0.ZU;2-H
Abstract
OBJECTIVE - To study whether 8-mm needles can reduce the frequency of intra muscular injections in diabetic children. RESEARCH DESIGN AND METHODS - We conducted a prospective crossover study in 50 children whose BMI was less than or equal to 60th percentile to compare two lengths of needles (12.7 and 8 mm) regarding the occurrence of intramu scular injections as assessed by ultrasonography. RESULTS - The frequency of intramuscular injections was 86% with the 12.7-m m needles and 38% with the 8-mm needles. The frequency of intramuscular inj ections was significantly reduced when using the 8-mm needles in the arms ( P < 0.01) and thighs (P < 0.001). The efficiency of 8-mm needles, as define d by an intramuscular injection with a 12.7-mm needle and a subcutaneous in jection with an 8-mm needle, was found for half of the children who injecte d in the arm and for two-thirds of the children who injected in the thigh. The subcutaneous tissue (SQT) thickness measured by ultrasonography with a skinfold was significantly higher (9.8 +/- 2.2 mm) in the group in which th e 8-mm needles were efficient than in the group in which they were not effi cient (6.8 +/- 2.1 mm, P < 0.0001). The efficiency of the 8-mm needle was n ot related to age, sex, BMI, percentile of BMI, injection device, or inject ion site. The sensibility and specificity of SQT thickness in predicting th e efficiency of the 8-mm needles were both 79%. CONCLUSIONS- Needles that are 8 mm long significantly reduce the risk of in tramuscular insulin injection in slim or normal-weight (BMI less than or eq ual to 60th percentile) diabetic children and adolescents.